744 - Medium-Term Efficacy and Long-Term Safety of Ileal Bile Acid Transporter Inhibitor, Elobixibat, in Chronic Constipation
Atsushi Nakajima(Yokohama City University), Michael Camilleri(CSIRO Manufacturing), Akira Ohta(Shinshu University), Jan P. Mattsson(Novartis (Switzerland)), Mitsunori Seki(EA Pharma (Japan)), Shinya Taniguchi(Konan University), Per‐Göran Gillberg(Uppsala University)
Cited by 0
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Laboratory characterisation of coal reservoir permeability for primary and enhanced coalbed methane recovery
|International Journal of Coal Geology|2009|477